Vol. 86, No. 4, 1979 February 28, 1979
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Pages 1192-1198
DEPLETION OF INTRACELLULAR PUTRESCINE AND SPERMIDINE BY o-DIFLUOROMETHYLORNITHINE DOES NOT INHIBIT PROLIFERATION OF 9L RAT BRAIN TUMOR CELLS
Jerome Seidenfeld2and Laurence J. Marton Brain Tumor ResearchCenter Department of Neurological Surgery University of California School of Medicine San Francisco, CA 94143 Received January 16, 1979 Incubation of 9L rat brain tumor cells with 25 mM DL-adifluoromethylornithine inhibits cell proliferation, while treatment with 10mM and 1 mM do not. All three concentrations cause equal degreesof depletion of intracellular putrescine and spermidine content, but have no effect on sperminecontent. These observations showthat 9L cells can continue to proliferate in spite of significant polyamine depletion and leadsone to question the role of polyamines in 9L cell replication. Theseobservations also suggestthat inhibition of 9L cell proliferation by 25 mM DL- cr-difluormethylornithine is probably not due to its effect on ornithine decarboxylase or on intracellular polyamine content. INTRODUCTION The current interest in elucidating the intracellular role(s) of the polyamines has led to the synthesisand investigation of a number of inhibitors of L-ornithine decarboxylase (ODC4, E.C.4.1.1.17)(1-Ii),the first enzyme in the polyamine biosynthetic pathway (12,131.Metcalf, et al showed(9) that DL-cGdifluoromethylornithine (DFMO), first synthesized by Bey and Vevert (81, is an enzyme-activated irreversible inhibitor of mammalianODC. Mamont, et al report (7) that DFMO treatment results in inhibition of proliferation of rat hepatoma, L1210murine leukemia, 1 . This work was supported by NC1 grants CA-15515 and CA-13525 and a gift from the Phi Beta Psi Sorority. LJM is the recipient of NC1 Research Career Develgpment Award CA-00 112. 3To whom reprint requests shouldbe addressed. 4Also in the Department of Laboratory Medicine. The abbreviations used are: ODC, ornithine decarboxylase; DFMO, DLGdifluoromethylornithine; Pu, putrescine; Sd, spermidine; Sp, spermine; HBSS,Hank’s balanced salt solution; neq, nanoequivalents;aMO, DL-a-methylornithine. 0006-291
X/79/041
192-07$01
.OO/ 0
Copyright @I I979 by Academic Press, Inc. All rights of reproduction in any form reserved.
1192
Vol. 86, No. 4, 1979
BIOCHEMICAL
and human prostatic effect
adenoma
cells --in vitro.
of DFMO to the observed
spermidine
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
decline
These authors
in intracellular
(Sd). DFMO was also shown (11) to prolong
of mice incubated
with L1210 leukemic
observations
on the effects
MATERIALS
AND METHODS
of DFMO
cells.
attribute
putrescine
this cytostatic (Pu) and
the mean survival
We report
time
here some preliminary
on VL rat brain tumor
cells grown --in vitro.
All chemicals used were of analytical grade. The DFMO used in this study was the generous gift of Merrell International Research Center, Strasbourg, France. Rat 9L brain tumor cells were grown in vitro 2s previously descrped (14). Cells were seeded into plastic Falcon flasks775 cm surface area, 10 cells/flask) in 13.5 ml of medium (14) 24-26 hours before starting an experiment, to allow cells to reach exponential growth before treatment (15). Cells were treated with 1.5 ml of a 10 fold concentrated solution of DFMO in Hank’s balanced salt solution (HBSS), adjusted to pH 7.2, that when added to the flask was diluted to the appropriate concentration. Control flasks were treated with 1.5 ml of HBSS. At various times after treatment the incubation medium was decanted, the cegs were haryested by trypsinization (0.25% trypsin and 0.02% Na EDTA in Ca+ -and Mg+ -free HBSS for 5 min at 37 O) and suspended in 12 m f of Ice . cold 0.02% Na2 EDTA in HBSS. Three flasks treated with each concentration of DFMO and three control flasks were harvested at each time point. The total number of cells/flask was measured by counting an aliquot of each cell suspension using a Royce Cell-Crit model 927-TC counter (Royce Instruments, Menlo Park, CA). To measure the intracellular polyamine content 6 ml of each cell suspension was sedimented by centrifugatpn and the cell pellet was sonicated in 8% 5-sulfosalicylic acid (250 @/IO cells). The homogenate was kept on ice for one hour to precipitate protein, centrifuged (8,000 xg for 10 min at 4’) and 50 ~1 of supernatant was analyzed for polyamine content using a Durrum Instruments Inc. (Sunnyvale, CA) D-500 amino acid analyzer as previously described (16) with the following modifications. An 11.5 cm (1.75mm i.d.1 stainless steel column was packed with a 16% cross-linked 10: pm diameter sulfonated polystyrene cation exchange resin (Durrum Chemical Co., Sunnyvale, CA). Four buffers used for sequential elution of the polyamines were prepared as follows. A stock buffer (Buffer IV), 2.40N KC1 and O.OVN potassium citrate (pH 5.56), to which 12 ml/l thiodiglycol and 0.5 ml/l liquified phenol were added, was diluted to prepare Buffers I-III as follows (stock:water): I, 1:4; II, 1:l; III, 4:l. The three polyamines were quantitated by fluorescense measurement of the chromophore produced by reaction with o-phthal aldehyde. RESULTS The effects Figure
of 25, 10, and 1 mM DFMO on VL cell proliferation
1. At 48 and 72 hours post treatment
only 65% and 52% as many cells respectively concentrations
of DFMO
produced
flasks containing as did control
much smaller
1193
degrees
are shown in
25 mM DFMO had flasks.
of inhibition
The lower of cell
Vol. 86, No. 4, 1979
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
6-
4.0 B 2 u 2i 5
3.6
2.4
Figure 1: Effect of DFMO on 9L cell proliferation. Rat 9L brain tumor cells were incubated in the absence (0) or in the presence of 1.0 mM (01, 10.0 mM (m), or 25.0 mM (A) DFMO. Three flasks at each concentration were harvested by trypsinization at each time point and counted using a Royce Cell-Crit Model 927-TC cell counter. Points represent the mean (+ SD) of three determinations. Figure
2: Effect of DFMO on 9L intracellular putrescine content. Rat 9L brain incubated in the absence (01 or in the presence of 1.0 mM (01, , or 25.0 mM (A) DFMO. Three flasks at each concentration were at each time point. Cells were pelleted, sonicated in 8% 5-sulfosalicylic acid, spun at 8000 x g and aliquots of the supernatants were analyzed for intracellular putrescine content with a Durrum D-500 amino acid analyzer. Points represent the mean (+ SD) of three determinations.
proliferation.
By 96 hours flasks with 10 or 1 mM DFMO had as many cells as did
controls. Figure
2 shows that all three concentrations
Pu content
to less than 0.1 nmol/106
lower
of detection
limit
than 2% of control cells did not increase Treatment
and analytical
at the same time.
during the remainder
with DFMO also resulted
(Fig. 3) which was maximal treatment
cells by 12 hours after
of our preparative
cells’ Pu content
intracellular
treatment. methods.
This is the It is also less
The Pu content
of treated
of the 96 hour study. in depletion
(to less than 4% of control
for all three concentrations
was faster for cells treated
of DFMO depleted
studied.
of intracellular
Sd content
levels) at 48 hours post
The rate of decline
of Sd eontent
with 25 mM DFMO than for those incubated
with lower
concentrations. Figure spermine
4 shows that there were no statistically
(Sp) content
between
control
significant
cells and cells treated
1194
differences
in
with 25, 10, or 1 mM
Vol. 86, No. 4, 1979
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
4 2 3
3
“0 7 %
2
4-
s l-
1 -l
03
20
40 HOURS 60
80
100
III
04
1 20
11
I
40 HOURS 60
[ 80
Figure 3: Effect of DFMO on VL intrac&ular spermidine content. Rat VL brain tumor cells were incubated in the absence (0) or in the presence of 1.0 mM (@I, 10.0 mM (m, or 25.0 mM (A DFMO. Three flasks at each concentration were harvested by trypsinization at each time point. Cells were pelleted, sonicated in 8% 5-sulfosalicylic acid, spun at 8000 x g and aliquots of the suspernatants were analyzed for intracellular spermidine content with a Durrum D-500 amino acid analyzer. Points represent the mean (+ SD) of three determinations. Figure 4: Effect of DFMO on VL intracellular spermine content. Rat VL brain tumor cells were incubated in the absence (0) or in the presence of 1.0 mM (a), 10.0 mM (m, or 25.0 m.M (A)DFMO. Three flasks at each concentration were harvested by trypsinization at each time point. Cells were pelleted, sonicated in 8% 5-sulfosalicylic acid, spun at 8000 x g, and aliquots of the supernatant were analyzed for intracellular spermine content with a Durrum D-500 amino acid analyzer. Points represent the mean (+ SD) of three determinations.
DFMO.
The total polyamine
content
sum of Sd content
plus Sp content
above-mentioned
concentrations
(in nanoequivalents
(neq )/lo6
cells) and the
(in the same units), for cells treated of DFMO, are shown in Figures
with the
5 and 6 respectively.
DISCUSSION Within
48 hours of incubation
of VL cells with 10 or 1 mM DFMO the cells lost
more than 98% and 96% of their normal 3). Nevertheless,
the parallel
hours post treatment
growth
these depleted
curves obtained
this is the first report
proliferate
at the same rate as controls complement
respectively
(Figs 2 and
show that from 48 to 72
cells grew at the same rate as controls
We believe
its normal
Pu and Sd content
of a wild-type
cell line that continues
in spite of depletion
of two of the three polyamines.
1195
(Fig. 1).
to
of more than 95% of
In addition,
the lack of
1
t 100
Vol.
40
86,
No.
4, 1979
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
r
tl 20
40
60
100
80
HOURS
I
I
I
20
-
I
I
40
I
60
I 80
HOURS
w
Figure 5: Effect of DFMO on VL intracellular total polyamine content. Rat VL brain tumor cells were incubated in the absence (0) or in the presence of 1.0 mM (01, 10.0 mM (m or 25.0 mM (& DFMO. Data skwn in Figures 2, 3, and 4 were used to calculate total polyamine content in neq/lO cells as (2 x Pu content) + (3 x Sd content) + (4 x Sp content). Points represent the mean (+ SD) of three determinations. Figure 6: Effect of DFMO on VL intracellular Sd plus Sp content. Tumor cells were incubated in the absence (0) or in the presence of 1.0 mM (e), 10.0 mM (m, or 25.0 mM (A) DFMO. Data shgwn in Figures 3 and 4 were used to calculate total Sd plus Sp content in neq/lO cells as (3 x Sd content) + (4 x Sp content). Points represent the mean (2 SD) of three determinations.
correlation action
of the degree of polyamine
for the three concentrations
proliferation but rather
to some non-ODC
and polyamine
control
of DFMO studied
levels.
We hypothesized
content
on VL cells, However,
of 10 mM
for controls
oM0,
(aM0) which
did not have a
Sp content
to 150% of controls.
CrMO to inhibit
VL cell proliferation,
to replicate
might possibly
of neq/106 cells of Sd and Sp. This parameter and cells treated
cells of all three polyamines
of VL cells,
on VL cell proliferation
could be due to the compensatory
that the cell’s ability
by the total number
content
of
Pu and Sd to less than 5% and 33% of
eM0 increased
(17) that the failure
that inhibition
on polyamine
of o-methylornithine
depleted
10 mM
implies
action.
(17) showed that 10 mM
in spite of Pu and Sd depletion, Sp and proposed
specific
work on the effects
effect
not differ
with the degree of cytostatic
by DFMO may not be due to effects
Previous
cytostatic
depletion
did decline
with 10 mM for treated
1196
aM0 although cells.
increase
in
be determined did total neq/106
I
I 100
Vol. 86, No. 4, 1979
The results hypothesis. decrease
BIOCHEMICAL
we report
Figures
here, however,
both total
resulting
clearly
polyamine
content
Sd depletion
at the same rate as controls.
complement
flasks containing
10 or 1 mM DFMO as in control
their normal inhibitors.
growth
described
indicating
to the effects
loss of greater
knowledge,
proliferation
et al (18) for a variant by the selective HMO,,
pressure
depletion.
with
HMO,
cells.
in spite of significant
of ODC to the
The data reported
by
Pu and Sd content,
Their observation polyamine
depletion
of normal is, to our
The cell line used in that study, however, pressure
at
QMO or DFMO does result in
than 90% of control
by selective
of
can proliferate
clone as “resistant
of polyamine of HMO,
in
we feel it may be more appropriately
do act on HMO,
the first such report.
clone produced
or more than
even in the presence
refer to the HMO,
that ODC inhibitors
rates of cellular
by Mamont,
These cells, designated
show that incubation
almost immediate
in spite of the
flasks at 96 hours post treatment.
rate for several generations
as resistant
with 10 or
of polyamines,
cell line produced
effect of ODC inhibitors,”
these authors
variant
“MO.
While these authors
anti-proliferative
reported
tissue culture with
Sp
of Sd plus Sp, there were as many cells present
results were recently
incubation
cells treated In addition,
complement
half their normal
clone of the hepatoma
of 9L cells.
and the absence of increased Nonetheless,
loss of more than 2/3 of the cells’ normal
continual
our previous
and total Sd plus Sp content
from DFMO treatment.
1 mM DFMO proliferate
Similar
argue against
5 and 6 show that both 10 and 1 mM DFMO significantly
This is due to both the greater content
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
rather
than a wild-type
was a
cell line such
as 9L. As we have discussed previously to study the role(s) of polyamines the intracellular intracellular
Pu content Sd levels.
not play a crucial unperturbed needed
our observations
in cell proliferation
among cell lines used
and division.
For example,
of unperturbed
9L cells is particularly
The results we report
here may indicate
that polyamines
or may, alternatively,
imply that
role in 9L cell replication
9L cells produce
to support
(17), 9L may be unique
nearly two orders of magnitude
their continued
proliferation.
may also be a characteristic
1197
Either
high relative
to do
more Pu and Sd than
of these explanations
unique to 9L cells.
for
Vol. 86, No. 4, 1979
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
REFERENCES 1. Williams-Ashman, H.G., Corti, A., and Tadolini, B. (1976)Ital. J. Biochem., 25, 5-32. 2. Abdel-Monem, M.M., Newton, N.E., and Weeks, C.E. (1974)J. Med. Chem., E, 447-451. 3. Harik, S.I. and Snyder, S.H. (1973)Biochim. Biophys. Acta., 327, 501-509. 4. Abdel-Monem, M.M., Newton, N.E., and Weeks, C.E. (1975)3. Med. Chem., 18, 945-948. 5. Relyea, N. and Rando, R.R. (1975) Biochem. Biophys. Res. Comm., 67, 392-402. 6. Heller, J.S., Canellakis, ES., Bussolotti, D.L., and Coward, J.K., (1975) Biochim. Biophys. Acta, %,197-207. 7. Mamont, P.S., Duchesne, M.C., Grove, J., and Bey, P. (1978). Biochem. Biophys. Res. Comm., 81, 58-66. 8. Bey, P., and Vevert, J.P. (1978)Tet. Letters, 1215-1218. 9. Metcalf, B.W., Bey, P., Danzin, C., Jung, M.J., Casara, P. and Vevert, J.P. (1978)J. Am. Chem. Sot., 100, 2551-2553. 10. Bey, P., Danzin, C., VanDorsselau, V., Mamont, P., Jung, M. and Tardif, C. (1978)J. Med. Chem., 2l, 50-55. II. Prakash, N.J., Schechter, P.J., Grove, J. and Koch-Weser, J. (1978) Cancer Res., 38, 3059-3062. 12. Cohen, S.S. (1971)Introduction to the Polyamines, Prentice-Hall, Englewood Cliffs, New Jersey. 13. Bachrach, U. (1973)Function of Naturally Occurring Polyamines, Academic Press,New York. 14. Heby., O., Marton, L.J., Wilson, C.B., and Martinez, H.M. (1975) J. Cell. Physiol, 86, 511-522. 15. Heby., O., Marton, L.J., Wilson, C.B., and Martinez, H.M. (1975) FEBS Letters, 50, l-4. 16. Marton, L.J. and Lee, P.Y.L. (1975)Clin. Chem., z, 1721-1724. 17. Seidenfeld, J. and Marton, L-J., submitted. IX. Mamont, P.S. Duchesne,M.C., Grove, J., and Tardif, C. (1978)Exp. Cell Res., ll5, 387-393.
1198